title: Alteration of vaginal elastin metabolism in women with pelvic organ prolapse.
abstract: OBJECTIVE
  To compare elastin metabolism in the vagina of women with and without pelvic organ prolapse and to define the regulation of this process by hormone therapy (HT).
  
  
  METHODS
  Eighty-seven histologically confirmed full-thickness vaginal biopsies were procured from study participants at time of surgery. Premenopausal women with no prolapse served as controls. Women with prolapse were divided into three groups: premenopausal, postmenopausal not on HT, and postmenopausal on HT. The epithelium was excised leaving the subepithelium, muscularis, and adventitia for analyses. The elastin precursor, tropoelastin, was measured by immunoblotting and mature elastin protein via a desmosine cross-link radioimmunoassay. Matrix metalloproteinases (MMPs)-2 and -9 were quantitated by gelatin zymography. Data were analyzed using Kruskal-Wallis test and post hoc analysis using the Mann-Whitney U test.
  
  
  RESULTS
  Tropoelastin (432%), mature elastin (55%), proMMP-9 (90%), and active MMP-9 (106%) were increased in women with prolapse relative to those in the control group while active MMP-2 (41%) was decreased. Comparison of tropoelastin and mature elastin values obtained from the same women showed them to be independently regulated (r=0.19). Interestingly, the highest amount of both proteins occurred in postmenopausal patients not on HT.
  
  
  CONCLUSIONS
  Elastin metabolism is altered in the vagina of women with prolapse relative to those in the control group, suggesting that vaginal tissue is rapidly remodeling in response to mechanical stretch. We found that elastin levels are highest in the absence of hormones.
authors.affiliation: From the Department of Obstetrics and Gynecology and Reproductive Sciences, Division of Urogynecology and Reconstructive Pelvic Surgery, and Magee-Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and Department of Biochemistry, University of Texas at Tyler, Tyler, Texas.
authors.forename: Wenjun
authors.initials: W
authors.lastname: Zong
authors.forename: Suzan E
authors.initials: SE
authors.lastname: Stein
authors.forename: Barry
authors.initials: B
authors.lastname: Starcher
authors.forename: Leslie A
authors.initials: LA
authors.lastname: Meyn
authors.forename: Pamela A
authors.initials: PA
authors.lastname: Moalli
mesh_terms: D000328:Adult; D004549:Elastin / Q000378:metabolism*; D005260:Female; D006801:Humans; D015151:Immunoblotting; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D008875:Middle Aged; D014333:Tropoelastin / Q000378:metabolism; D014596:Uterine Prolapse / Q000378:metabolism*; D014621:Vagina / Q000737:chemistry*; D055815:Young Adult
chemical_list: D014333:Tropoelastin; D004549:Elastin; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9
references.citation: Exp Mol Pathol. 1980 Aug;33(1):15-24
references.pmid: 7409083
references.citation: Nat Biotechnol. 1999 Oct;17(10):979-83
references.pmid: 10504698
references.citation: Circulation. 2000 Jul 11;102(2):225-30
references.pmid: 10889135
references.citation: Am J Obstet Gynecol. 2001 Jun;184(7):1496-501; discussion 1501-3
references.pmid: 11408873
references.citation: Tissue Eng. 2007 Jun;13(6):1313-23
references.pmid: 17518717
references.citation: Int Urogynecol J Pelvic Floor Dysfunct. 2007 Jan;18(1):43-8
references.pmid: 16547686
references.citation: Int Urogynecol J Pelvic Floor Dysfunct. 2008 May;19(5):723-9
references.pmid: 18183343
references.citation: Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1164-71
references.pmid: 9672078
references.citation: Hum Reprod. 2006 May;21(5):1266-73
references.pmid: 16452154
references.citation: Lancet. 2007 Mar 24;369(9566):1027-38
references.pmid: 17382829
references.citation: Br J Urol. 1987 Jun;59(6):529-32
references.pmid: 3690183
references.citation: Am J Obstet Gynecol. 2003 Jan;188(1):108-15
references.pmid: 12548203
references.citation: Am J Pathol. 2000 Sep;157(3):885-93
references.pmid: 10980128
references.citation: J Biol Chem. 1997 Jul 18;272(29):18071-6
references.pmid: 9218437
references.citation: Biol Reprod. 2009 Feb;80(2):367-74
references.pmid: 18987329
references.citation: Biol Chem. 1997 Mar-Apr;378(3-4):265-71
references.pmid: 9165080
references.citation: Am J Obstet Gynecol. 2004 Mar;190(3):620-7
references.pmid: 15041990
references.citation: Obstet Gynecol. 2001 Oct;98(4):646-51
references.pmid: 11576582
references.citation: Am J Obstet Gynecol. 1992 Jun;166(6 Pt 1):1717-24; discussion 1724-8
references.pmid: 1615980
references.citation: Am J Pathol. 2007 Feb;170(2):578-89
references.pmid: 17255326
references.citation: Obstet Gynecol. 2005 Nov;106(5 Pt 1):953-63
references.pmid: 16260512
references.citation: J Clin Invest. 2002 Sep;110(5):625-32
references.pmid: 12208863
references.citation: Am J Physiol Lung Cell Mol Physiol. 2000 May;278(5):L974-80
references.pmid: 10781428
references.citation: Circ Res. 2007 Aug 31;101(5):512-22
references.pmid: 17641224
references.citation: Biochem J. 1963 Oct;89:75-82
references.pmid: 14097370
references.citation: Circulation. 2004 Nov 30;110(22):3480-7
references.pmid: 15545515
references.citation: Int Urogynecol J Pelvic Floor Dysfunct. 2007 Dec;18(12):1481-9
references.pmid: 17982711
references.citation: Cardiovasc Drugs Ther. 2000 Jun;14(3):303-7
references.pmid: 10935152
references.citation: Atherosclerosis. 1998 Oct;140(2):281-95
references.pmid: 9862271
references.citation: Am J Pathol. 2006 Feb;168(2):519-28
references.pmid: 16436666
references.citation: Connect Tissue Res. 1995;31(2):133-40
references.pmid: 15612329
references.citation: BJU Int. 2007 Aug;100(2):346-50
references.pmid: 17532852
references.citation: Int Urogynecol J Pelvic Floor Dysfunct. 2007 Nov;18(11):1367-70
references.pmid: 17453126